As Q1 earnings season comes to a close, it’s time to take stock of this quarter's best and worst performers amongst the data analytics stocks, including Alteryx (NYSE:AYX) and its peers.
Organizations generate a lot of data that is stored in silos, often in incompatible formats, making it slow and costly to extract actionable insights, which in turn drives demand for modern cloud-based data analysis platforms that can efficiently analyze the silo-ed data.
The 5 data analytics stocks we track reported a weaker Q1; on average, revenues beat analyst consensus estimates by 1.92%, while on average next quarter revenue guidance was 3.4% under consensus. Tech stocks have been hit the hardest as investors start to value profits over growth, but data analytics stocks held their ground better than others, with the share prices up 11.6% since the previous earnings results, on average.
Weakest Q1: Alteryx (NYSE:AYX)
Initially created as a way to organise census data for the government, Alteryx (NYSE:AYX) provides software that helps companies automate and analyse their internal data processes.
Alteryx reported revenues of $199.1 million, up 26.1% year on year, missing analyst expectations by 0.49%. It was a weak quarter for the company, with underwhelming revenue guidance for the next quarter and decelerating customer growth.
"Alteryx delivered a solid first quarter with annualized recurring revenue (ARR) growth of 25% year-over-year, driven by robust growth with our larger enterprise customers," said Mark Anderson, CEO of Alteryx,
Alteryx achieved the fastest revenue growth but had the weakest performance against analyst estimates of the whole group. The company lost 20 customers and ended up with a total of 8,338. The stock is down 21.6% since the results and currently trades at $39.97.
Best Q1: Health Catalyst (NASDAQ:HCAT)
Founded by healthcare professionals Tom Burton and Steve Barlow in 2008, Health Catalyst (NASDAQ:HCAT) provides data and analytics technology to healthcare organizations, enabling them to improve care and lower costs.
Health Catalyst reported revenues of $73.9 million, up 8.49% year on year, beating analyst expectations by 3.66%. It was a slower quarter for the company, with underwhelming revenue guidance for the next quarter and full year.
The stock is down 4.36% since the results and currently trades at $11.42.
Is now the time to buy Health Catalyst? Access our full analysis of the earnings results here, it's free.
Founded by Josh James after selling his former business Omniture to Adobe, Domo (NASDAQ:DOMO) provides business intelligence software that allows managers to access and visualize critical business metrics in real-time, using their smartphones.
Domo reported revenues of $79.5 million, up 6.71% year on year, in line with analyst expectations. It was a weaker quarter for the company, with underwhelming revenue guidance for the next quarter.
Domo had the slowest revenue growth in the group. The stock is down 2.63% since the results and currently trades at $14.42.
Started by Peter Thiel after seeing US defence agencies struggle in the aftermath of the 2001 terrorist attacks, Palantir (NYSE:PLTR) offers software as a service platform that helps government agencies and large enterprises use data to make better decisions.
Palantir reported revenues of $525.2 million, up 17.7% year on year, beating analyst expectations by 3.8%. Despite the stock rising on the results. it was a weaker quarter for the company, with underwhelming revenue guidance for the next quarter.
Palantir scored the strongest analyst estimates beat and highest full year guidance raise among the peers. The stock is up 96.6% since the results and currently trades at $15.28.
Born out of a failed voice recognition startup by founder Spenser Skates, Amplitude (NASDAQ:AMPL) is data analytics software helping companies improve and optimize their digital products.
Amplitude reported revenues of $66.5 million, up 25.3% year on year, beating analyst expectations by 1.9%. It was a weaker quarter for the company, with revenue guidance for the next quarter and full year missing analysts' expectations.
Amplitude had the weakest full year guidance update among the peers. The company added 181 customers to a total of 2,175. The stock is down 11% since the results and currently trades at $10.34.
The author has no position in any of the stocks mentioned